AU7939487A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
AU7939487A
AU7939487A AU79394/87A AU7939487A AU7939487A AU 7939487 A AU7939487 A AU 7939487A AU 79394/87 A AU79394/87 A AU 79394/87A AU 7939487 A AU7939487 A AU 7939487A AU 7939487 A AU7939487 A AU 7939487A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79394/87A
Inventor
Charanjit Rai Behl
Joel Unowsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU7939487A publication Critical patent/AU7939487A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
AU79394/87A 1986-10-07 1987-10-06 Pharmaceutical compositions Abandoned AU7939487A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91615086A 1986-10-07 1986-10-07
US916150 1986-10-07

Publications (1)

Publication Number Publication Date
AU7939487A true AU7939487A (en) 1988-04-14

Family

ID=25436780

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79394/87A Abandoned AU7939487A (en) 1986-10-07 1987-10-06 Pharmaceutical compositions

Country Status (14)

Country Link
EP (1) EP0263493A3 (en)
JP (1) JPS6396138A (en)
CN (1) CN87106855A (en)
AU (1) AU7939487A (en)
DK (1) DK521487A (en)
FI (1) FI874382A (en)
HU (1) HU196903B (en)
IE (1) IE872667L (en)
IL (1) IL84099A0 (en)
MC (1) MC1878A1 (en)
NO (1) NO874193L (en)
PT (1) PT85871B (en)
ZA (1) ZA876930B (en)
ZW (1) ZW18787A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0643315B2 (en) * 1988-01-20 1994-06-08 東京田辺製薬株式会社 Bile acid composition
DD293494A5 (en) * 1989-03-29 1991-09-05 Fahlberg List Gmbh Magdeburg PROCESS FOR PREPARING A GALENIC PREPARATION WITH OPTIMAL BIODEGRADABILITY OF THE ACTIVE 2-HYDROXY-5-METHYLLAURO-PHENONOXIM (HMLO)
CA2033714A1 (en) * 1990-01-25 1991-07-26 Alberto Ferro Pharmaceutical preparations
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US8093207B2 (en) * 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
US8318663B2 (en) 2008-11-26 2012-11-27 Satiogen Pharmaceuticals, Inc. Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent
CA2744817C (en) 2008-11-26 2020-07-07 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of obesity and diabetes
ES2552657T3 (en) 2010-05-26 2015-12-01 Satiogen Pharmaceuticals, Inc. Inhibitors of the recycling of bile acids and satiogens for the treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
EA201891154A1 (en) 2011-10-28 2019-02-28 ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи INHIBITORS OF BILIC ACID RECYCLING IN THE TREATMENT OF CHOLESTATIC DISEASES OF THE LIVER IN CHILDREN
CN105617353A (en) * 2016-01-04 2016-06-01 李志海 Oral administration composition of colistin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562007A (en) * 1978-11-02 1980-05-10 Fujisawa Pharmaceut Co Ltd Preparation for rectal administration
JPS57158719A (en) * 1981-03-24 1982-09-30 Fujisawa Pharmaceut Co Ltd Rectal administration pharmaceutical
US4760059A (en) * 1985-08-05 1988-07-26 Hoffmann-La Roche Inc. Rectal dosage form

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides

Also Published As

Publication number Publication date
DK521487A (en) 1988-04-08
FI874382A0 (en) 1987-10-06
ZW18787A1 (en) 1988-05-25
DK521487D0 (en) 1987-10-05
ZA876930B (en) 1988-05-25
HUT45395A (en) 1988-07-28
IE872667L (en) 1988-04-07
NO874193L (en) 1988-04-08
EP0263493A2 (en) 1988-04-13
MC1878A1 (en) 1989-01-24
CN87106855A (en) 1988-04-20
PT85871B (en) 1990-01-17
FI874382A (en) 1988-04-08
HU196903B (en) 1989-02-28
EP0263493A3 (en) 1989-06-14
JPS6396138A (en) 1988-04-27
PT85871A (en) 1987-11-01
IL84099A0 (en) 1988-03-31
NO874193D0 (en) 1987-10-06

Similar Documents

Publication Publication Date Title
GB2196964B (en) Pharmaceutical compositions
AU4148989A (en) Pharmaceutical compositions
GB8716301D0 (en) Pharmaceutical compositions
AU3674489A (en) Pharmaceutical compositions
GB8714625D0 (en) Pharmaceutical compositions
AU7756487A (en) Pharmaceutical formulations
GB8708587D0 (en) Pharmaceutical compositions
GB8618259D0 (en) Pharmaceutical compositions
GB2191696B (en) Pharmaceutical compositions
AU7336487A (en) Pharmaceutical compositions
AU607451B2 (en) Pharmaceutical compositions
AU1925488A (en) Pharmaceutical compositions
AU7939487A (en) Pharmaceutical compositions
AU1928988A (en) Pharmaceutical compositions
GB2188235B (en) Pharmaceutical compositions
AU7762287A (en) Freeze-dried pharmaceutical compositions
AU8292987A (en) Pharmaceutical compositions
AU1635588A (en) Pharmaceutical compositions
GB8621756D0 (en) Pharmaceutical compositions
GB8620073D0 (en) Pharmaceutical compositions
AU587505B2 (en) Pharmaceutical compositions
AU1507688A (en) Pharmaceutical compositions
GB8615041D0 (en) Pharmaceutical compositions
AU7819887A (en) Pharmaceutical composition
AU578657B2 (en) Pharmaceutical compositions